Israel’s DreaMed Diabetes said on Monday that the U.S. Food and Drug Administration has approved its Advisor Pro software to help manage diabetes treatment.
Read more on Haaretz here.
Israel’s DreaMed Diabetes said on Monday that the U.S. Food and Drug Administration has approved its Advisor Pro software to help manage diabetes treatment.
Read more on Haaretz here.
![[BioCatch in Find Biometrics] Behavioral Biometrics Can Prevent Account Sharing in Gig Economy: BioCatch](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
